Search filters

List of works by Daisuke Takahari

A Phase II Study of Systemic Chemotherapy with Docetaxel, Cisplatin, and S-1 (DCS) Followed by Surgery in Gastric Cancer Patients with Extensive Lymph Node Metastasis: Japan Clinical Oncology Group Study JCOG1002 ⬇️

scientific article published on April 23, 2012

A Retrospective Comparison of Docetaxel and Paclitaxel for Patients with Advanced or Recurrent Esophageal Cancer Who Previously Received Platinum-Based Chemotherapy ⬇️

scientific article published on November 17, 2011

A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab ⬇️

scientific article published on May 12, 2011

A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer ⬇️

scientific article published on February 8, 2012

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study

scientific article published on 06 March 2019

A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.

scientific article published on 14 June 2016

A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.

scientific article published on 14 September 2017

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

scientific article published on 27 August 2015

Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer

scientific article published on 05 June 2017

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer ⬇️

scientific article published on March 1, 2011

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer

scientific article

Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival

scientific article published on 06 January 2020

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.

scientific article published on 9 April 2018

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer

scientific article published on 17 October 2018

Conversion Chemotherapy Using Cetuximab plus FOLFIRI Followed by Bevacizumab plus mFOLFOX6 in Patients with Unresectable Liver Metastases from Colorectal Cancer ⬇️

scientific article published on August 11, 2011

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer

scientific article published on 01 May 2019

Correction to: Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

scientific article published on 01 November 2018

Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer ⬇️

scientific article published on 19 June 2017

Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.

scientific article

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel.

scientific article published on 8 March 2018

Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy

scientific article published on January 1, 2010

Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study.

scientific article published on 20 July 2017

Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.

scientific article published in September 2017

Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.

scientific article published on 26 April 2018

Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer ⬇️

scientific article published on 01 September 2010

Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study

scientific article published on 03 July 2019

Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer

scientific article published in May 2010

Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study

scientific article published on 9 December 2009

Improvement of Oral Intake following Chemotherapy in Gastric Cancer Patients with an Inability to Eat ⬇️

scientific article published on January 1, 2010

Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002)

scientific article published on 12 September 2019

Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research

scientific article published on 21 October 2020

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

scientific article published on 23 November 2018

Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer

scientific article published on 17 May 2019

Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma

scientific article published on 09 December 2019

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma ⬇️

scientific article published on February 16, 2011

Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer

scientific article published on 07 May 2019

Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer

scientific article published on 07 August 2013

Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer ⬇️

scientific article published on August 19, 2011

Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer

scientific article published on 13 July 2018

Prognostic Impact of the 6th and 7th American Joint Committee on Cancer TNM Staging Systems on Esophageal Cancer Patients Treated With Chemoradiotherapy ⬇️

scientific article published on February 28, 2011

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article published on 01 February 2019

Recovery from Choriocarcinoma Syndrome Associated with a Metastatic Extragonadal Germ Cell Tumor Hemorrhage

scientific article published on January 2016

Recursive Partitioning Analysis for New Classification of Patients With Esophageal Cancer Treated by Chemoradiotherapy ⬇️

scientific article published on March 11, 2012

Retrospective analysis of cetuximab monotherapy for patients with irinotecan-intolerant metastatic colorectal cancer ⬇️

scientific article published on March 26, 2011

Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis

scientific article published on 26 July 2017

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.

scientific article

S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT stud

scientific article

Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study

scientific article published on 25 June 2019

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer

scientific article published on 07 May 2019

Second-line chemotherapy for patients with advanced gastric cancer.

scientific article published on 4 March 2017

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer ⬇️

scientific article published on September 5, 2010

Serum Concentration of Fentanyl During Conversion From Intravenous to Transdermal Administration to Patients With Chronic Cancer Pain ⬇️

scientific article published on June 1, 2013

Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study

scientific article published on 31 May 2019

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer

scientific article published on 01 November 2018

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

scientific article published on 01 May 2018

Upcoming first-line chemotherapy for HER2-negative gastric cancer in Japan: which patients benefit from immunotherapy?

scientific article published on 15 June 2020

Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials.

scientific article

[Chemotherapy for patients with advanced gastric cancer]

scientific article published on 01 January 2018

Paulina is supported by:

About Paulina

Help